| Literature DB >> 28256594 |
Dandan Duan1,2, Yuanli Dong3, Hua Zhang2, Yingxin Zhao2, Yutao Diao2, Yi Cui4, Juan Wang5, Qiang Chai2, Zhendong Liu2.
Abstract
This study evaluated the association between empty-nest-related psychological distress and the progression of white matter lesions (WMLs) and cognitive impairment in 219 elderly subjects aged 60 years or over. Psychological distress was assessed using the University of California at Los Angeles Loneliness Scale (UCLA-LS) and Geriatric Depression Scale (GDS) Short-Form. Cognitive function was evaluated using the MMSE and MoCA. White matter hyperintensities (WMH) were assessed using magnetic resonance imaging. After 5.2-year follow-up, the reductions in MMSE and MoCA scores and the increases in periventricular (P)WMH, deep (D)WMH, and total WMH volumes in the empty-nest elderly were greater than those in the non-empty-nest elderly (P < 0.05). The reduced MMSE and MoCA scores and increased volumes of PWMH and total WMH in the empty-nest elderly living alone were greater than those in the empty-nest elderly living with a spouse (P < 0.05). UCLA-LS and GDS scores were significantly and independently associated with reduced MMSE and MoCA scores and the increased volumes of PWMH, DWMH, and total WMH. The results indicate that empty-nest-related psychological distress is associated with progression of WMLs and cognitive impairment in the elderly.Entities:
Mesh:
Year: 2017 PMID: 28256594 PMCID: PMC5335556 DOI: 10.1038/srep43816
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of subject enrollment and screening.
Characteristics and demographics of participants at baseline.
| Control group ( | Couples group ( | Single group ( | ||
|---|---|---|---|---|
| Age, years | 69.69 ± 5.75 | 70.46 ± 4.81 | 69.41 ± 5.83 | 0.140 |
| Sex, F/M | 39/44 | 35/35 | 37/29 | 0.541 |
| Drinker, | 30 (36.14) | 19 (27.14) | 14 (21.21) | 0.127 |
| Smoker, | 9 (10.84) | 4 (5.71) | 9 (13.64) | 0.293 |
| Education, years | 9.70 ± 4.29 | 9.41 ± 3.76 | 7.82 ± 4.48* | 0.018 |
| Hypertension history, | 56 (67.47) | 56 (80.00) | 61 (92.42)*,† | 0.001 |
| Antihypertension, | 44 (78.57) | 51 (91.07) | 54 (88.52) | 0.096 |
| Diabetes history, | 11 (13.25) | 7 (10.00) | 6 (9.09) | 0.687 |
| Anti-diabetes, | 11 (100.00) | 7 (100.00) | 6 (100.00) | 1.000 |
| Body mass index, kg/m2 | 24.91 ± 3.23 | 24.79 ± 3.43 | 25.06 ± 3.64 | 0.898 |
| Systolic blood pressure, mm Hg | 137.58 ± 14.41 | 145.37 ± 16.87* | 154.89 ± 13.65*,† | <0.001 |
| Diastolic blood pressure, mm Hg | 70.04 ± 10.07 | 73.64 ± 10.37 | 71.68 ± 11.19 | 0.111 |
| Total cholesterol, mmol/L | 4.63 ± 0.87 | 4.72 ± 0.78 | 4.91 ± 0.69 | 0.102 |
| Triglycerides, mmol/L | 1.56 ± 0.55 | 1.57 ± 0.64 | 1.63 ± 0.57 | 0.737 |
| High-density lipoprotein cholesterol, mmol/L | 1.24 ± 0.31 | 1.22 ± 0.29 | 1.22 ± 0.31 | 0.882 |
| Low-density lipoprotein cholesterol, mmol/L | 2.72 ± 0.65 | 2.81 ± 0.56 | 2.95 ± 0.52 | 0.060 |
| Fasting plasma glucose, mmol/L | 5.43 ± 0.70 | 5.53 ± 0.67 | 5.48 ± 0.67 | 0.689 |
Results are presented as the mean ± standard deviation. *P < 0.05, compared to control group; †P < 0.05, compared to couples group.
Baseline variables of psychological outcome, global cognitive function, and brain MRI.
| Control group ( | Couples group ( | Single group ( | ||
|---|---|---|---|---|
| Psychological outcome | ||||
| UCLA-LS score, points | 29.64 ± 6.53 | 36.13 ± 7.01* | 47.20 ± 7.31*,† | <0.001 |
| GDS score, points | 4.45 ± 2.45 | 5.77 ± 2.68* | 8.50 ± 2.72*,† | <0.001 |
| Global cognitive function | ||||
| MMSE score, points | 28.00 (26.00, 29.00) | 27.00 (26.75, 28.00) | 27.00 (26.00, 28.00) | 0.087 |
| MoCA score, points | 27.00 (26.00, 28.00) | 26.00 (26.00, 28.00) | 26.00 (25.00, 27.00) | 0.063 |
| Brain MRI | ||||
| PWMH, mL | 4.66 ± 2.91 | 5.06 ± 2.81 | 4.93 ± 2.65 | 0.675 |
| DWMH, mL | 1.66 ± 0.86 | 1.64 ± 0.94 | 1.53 ± 0.87 | 0.475 |
| Total WMH, mL | 6.32 ± 3.33 | 6.70 ± 3.22 | 6.46 ± 3.05 | 0.766 |
Results are presented as the mea ersity of California at Los Angeles Loneliness Scale; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PWMH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; WMH, white matter hyperintensities. *P < 0.05, compared to control group; †P < 0.05, compared to couples group.
Figure 2Trends of global cognitive impairment in the elderly in relation to different lifestyles at the annual measurement over a 5-year follow-up period.
Results are presented as the mean. (a) Trends of the mean MMSE scores at the annual measurement in three groups; (b) trends of the mean MoCA scores at the annual measurement in three groups. MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment.
Figure 3Progression of global cognitive impairment in the elderly in relation to different lifestyles over a 5-year follow-up period.
Results are presented as the mean ± standard deviation or median with IQR. (a) Differences in the score of MMSE and MoCA between baseline and final follow-up among three groups; (b) changes in the percentages of score of MMSE and MoCA between baseline and final follow-up among three groups. MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment. *P < 0.05, compared to baseline; †P < 0.05, compared to control group; ‡P < 0.05, compared to couples group.
Figure 4Progression of white matter lesions in the elderly in relation to different lifestyle over a 5-year follow-up period.
The results are presented as the mean ± standards. (a) Differences in the volume of PWMH, DWMH, and total WMH between baseline and final follow-up among three groups; (b) change percentages of volume of PWMH, DWMH, and total WMH between baseline and final follow-up among three groups. PWMH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; WMH, white matter hyperintensities. *P < 0.05, compared to baseline; †P < 0.05, compared to control group; ‡P < 0.05, compared to couples group.
Correlation of psychological outcome with global cognitive function and brain WMH in all participants.
| Change of MMSE | Change of MoCA | Change of PWMH | Change of DWMH | Change of total WMH | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Correlation coefficient | Correlation coefficient | Correlation coefficient | Correlation coefficient | Correlation coefficient | ||||||
| Differences between baseline and the final follow-up | ||||||||||
| UCLA-LS score, points | −0.487* | <0.001 | −0.531 | <0.001 | 0.259 | <0.001 | 0.248 | <0.001 | 0.289 | <0.001 |
| GDS score, points | −0.389* | <0.001 | 0.434 | <0.001 | 0.249 | <0.001 | 0.283 | <0.001 | 0.267 | <0.001 |
| Change percentages over a 5-year follow-up period | ||||||||||
| UCLA-LS score, points | −0.495 | <0.001 | −0.536 | <0.001 | 0.599 | <0.001 | 0.467 | <0.001 | 0.612 | <0.001 |
| GDS score, points | −0.393 | <0.001 | −0.439 | <0.001 | 0.449 | <0.001 | 0.401 | <0.001 | 0.484 | <0.001 |
*Spearman correlation coefficients. Unit of difference of variables between baseline and the final follow-up: change of MMSE, point; change of MoCA, point; change of PWMH, mL; change of DWMH, mL; change of WMH, mL. Unit of change percentage of variables between baseline and final follow-up, %. UCLA-LS, University of California at Los Angeles Loneliness Scale; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PWMH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; WMH, white matter hyperintensities.
Associations of psychological outcome with global cognitive function and brain WMH in all participants after adjusting for confounders.
| Change of MMSE* | Change of MoCA* | Change of PWMH† | Change of DWMH† | Change of total WMH† | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Beta coefficient (95% C.I.) | Beta coefficient (95% C.I.) | Beta coefficient (95% C.I.) | Beta coefficient (95% C.I.) | Beta coefficient (95% C.I.) | ||||||
| Differences between baseline and the final follow-up | ||||||||||
| UCLA-LS score, point | −0.060 (−0.080, −0.040) | <0.001 | −0.050 (−0.072, −0.029) | <0.001 | 0.012 (0.001, 0.022) | 0.027 | 0.002 (0.001, 0.003) | 0.001 | 0.013 (0.001, 0.024) | 0.027 |
| GDS score, point | −0.052 (−0.093, −0.011) | 0.010 | −0.066 (−0.112, 0.020) | 0.037 | 0.030 (0.009, 0.051) | 0.008 | 0.015 (0.008, 0.022) | <0.001 | 0.039 (0.004, 0.074) | 0.028 |
| Change percentages over a 5-year follow-up period | ||||||||||
| UCLA-LS score, points | −0.218 (−0.291, −0.146) | <0.001 | −0.184 (−0.266, −0.103) | <0.001 | 0.347 (0.281, 0.413) | <0.001 | 0.190 (0.099, 0.282) | <0.001 | 0.271 (0.199, 0.344) | <0.001 |
| GDS score, points | −0.214 (−0.361, −0.67) | <0.001 | −0.255 (−0.414, −0.096) | 0.017 | 0.179 (0.096, 0.262) | <0.001 | 0.270 (0.116, 0.424) | <0.001 | 0.214 (0.075, 0.353) | <0.001 |
Independent variables include age, sex, smoking (yes or no), alcohol consumption (yes or no), education, body mass index, history of hypertension (yes or no), use of antihypertensive agents (yes or no), history of diabetes mellitus (yes or no), use of hypoglycemic agents (yes or no), blood pressure, fasting blood lipid and glucose levels, UCLA-LS, and GDS. *Independent variables also include baseline total WMH. †Independent variables also include baseline MMSE score. Unit of difference of variables between baseline and the final follow-up: change of MMSE, point; change of MoCA, point; change of PWMH, mL; change of DWMH, mL; change of WMH, mL. Unit of change percentage of variables between baseline and final follow-up, %. UCLA-LS, University of California at Los Angeles Loneliness Scale; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PWMH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; WMH, white matter hyperintensities.